Bionomics (BNO) is an Australian biopharmaceutical company specialising in ion channel drug discovery for central nervous system (CNS) disorders such as anxiety and post-traumatic stress disorder (PTSD). BNO also offers contract and partnered discovery based on its proprietary technology platforms: MultiCore and ionX. The group sales model includes fees-for-service, licensing income, and royalties from successful partnered products. In fiscal 2018, its strategy has been to focus on the develo
03 Sep 2018
FY’18 – focus on PTSD drug development
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
FY’18 – focus on PTSD drug development
- Published:
03 Sep 2018 -
Author:
Martin Hall -
Pages:
10
Bionomics (BNO) is an Australian biopharmaceutical company specialising in ion channel drug discovery for central nervous system (CNS) disorders such as anxiety and post-traumatic stress disorder (PTSD). BNO also offers contract and partnered discovery based on its proprietary technology platforms: MultiCore and ionX. The group sales model includes fees-for-service, licensing income, and royalties from successful partnered products. In fiscal 2018, its strategy has been to focus on the develo